$REPL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Replimune Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Replimune Group, Inc.. Get notifications about new insider transactions in Replimune Group, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Option Exercise | A | 33.99 | 110,000 | 3,738,900 | 110,000 | |
May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Grant | A | 0.00 | 73,333 | 0 | 73,333 | 0 to 73.3 K |
May 05 2021 | REPL | Replimune Group, I ... | Patel Sushil | Chief Commercial Of ... | Option Exercise | A | 36.75 | 125,000 | 4,593,750 | 125,000 | |
May 05 2021 | REPL | Replimune Group, I ... | Patel Sushil | Chief Commercial Of ... | Grant | A | 0.00 | 88,333 | 0 | 88,333 | 0 to 88.3 K |
Apr 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 29.98 | 2,700 | 80,946 | 895,809 | 898.5 K to 895.8 K (-0.30 %) |
Apr 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 30.69 | 27,300 | 837,837 | 898,509 | 925.8 K to 898.5 K (-2.95 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | A | 31.58 | 51,250 | 1,618,475 | 51,250 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Grant | A | 0.00 | 34,165 | 0 | 210,159 | 176 K to 210.2 K (+19.41 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Pirzkall Andrea | Chief Medical Offic ... | Option Exercise | A | 31.58 | 30,750 | 971,085 | 30,750 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Pirzkall Andrea | Chief Medical Offic ... | Grant | A | 0.00 | 20,500 | 0 | 21,500 | 1,000 to 21.5 K (+2,050.00 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | A | 31.58 | 69,050 | 2,180,599 | 69,050 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Grant | A | 0.00 | 46,035 | 0 | 46,035 | 0 to 46 K |
Apr 05 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Option Exercise | A | 31.58 | 115,300 | 3,641,174 | 115,300 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Grant | A | 0.00 | 76,865 | 0 | 1,820,983 | 1.7 M to 1.8 M (+4.41 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Option Exercise | A | 31.58 | 128,125 | 4,046,188 | 128,125 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Grant | A | 0.00 | 85,415 | 0 | 1,340,712 | 1.3 M to 1.3 M (+6.80 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Option Exercise | A | 31.58 | 58,925 | 1,860,852 | 58,925 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Grant | A | 0.00 | 39,285 | 0 | 925,809 | 886.5 K to 925.8 K (+4.43 %) |
Apr 05 2021 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Pucci Paolo | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Weinand Dieter | Director | Option Exercise | A | 31.58 | 24,750 | 781,605 | 24,750 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Slootweg Hugo Alexander | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | SLATTERY JOSEPH P | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
Mar 17 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 32.67 | 100 | 3,267 | 886,524 | 886.6 K to 886.5 K (-0.01 %) |
Mar 17 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 33.22 | 18,518 | 615,168 | 886,624 | 905.1 K to 886.6 K (-2.05 %) |
Mar 17 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 34.06 | 11,382 | 387,671 | 905,142 | 916.5 K to 905.1 K (-1.24 %) |
Feb 11 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | 10% Owner | Sell | S | 45.00 | 5,249 | 236,205 | 5,141,321 | 5.1 M to 5.1 M (-0.10 %) |
Jan 28 2021 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 46.14 | 5,558 | 256,446 | 946,000 | 951.6 K to 946 K (-0.58 %) |
Jan 28 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 46.04 | 3,393 | 156,214 | 5,283,682 | 5.3 M to 5.3 M (-0.06 %) |
Jan 28 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.34 | 26,957 | 1,222,230 | 5,287,075 | 5.3 M to 5.3 M (-0.51 %) |
Jan 26 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Sell | S | 43.99 | 29,803 | 1,311,034 | 1,744,118 | 1.8 M to 1.7 M (-1.68 %) |
Jan 26 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Sell | S | 44.87 | 30,197 | 1,354,939 | 1,773,921 | 1.8 M to 1.8 M (-1.67 %) |
Jan 26 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.03 | 3,269 | 147,203 | 5,314,032 | 5.3 M to 5.3 M (-0.06 %) |
Jan 26 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.05 | 8,090 | 364,455 | 5,317,301 | 5.3 M to 5.3 M (-0.15 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 42.40 | 7,632 | 323,597 | 1,255,297 | 1.3 M to 1.3 M (-0.60 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.15 | 800 | 34,520 | 1,262,929 | 1.3 M to 1.3 M (-0.06 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.02 | 9,409 | 404,775 | 1,263,729 | 1.3 M to 1.3 M (-0.74 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.71 | 6,059 | 264,839 | 1,273,138 | 1.3 M to 1.3 M (-0.47 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 44.95 | 1,100 | 49,445 | 1,279,197 | 1.3 M to 1.3 M (-0.09 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.06 | 100 | 4,306 | 1,280,297 | 1.3 M to 1.3 M (-0.01 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.61 | 7,448 | 324,807 | 1,280,397 | 1.3 M to 1.3 M (-0.58 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 44.78 | 17,452 | 781,501 | 1,287,845 | 1.3 M to 1.3 M (-1.34 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 5,727 | 5,784 | 73,203 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 29,273 | 29,566 | 78,930 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 20,000 | 20,200 | 108,203 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 42.38 | 5,127 | 217,282 | 175,994 | 181.1 K to 176 K (-2.83 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 43.24 | 600 | 25,944 | 181,121 | 181.7 K to 181.1 K (-0.33 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 5,727 | 5,784 | 181,721 | 176 K to 181.7 K (+3.25 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 43.58 | 29,273 | 1,275,717 | 175,994 | 205.3 K to 176 K (-14.26 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 29,273 | 29,566 | 205,267 | 176 K to 205.3 K (+16.63 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 45.02 | 20,000 | 900,400 | 175,994 | 196 K to 176 K (-10.20 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 20,000 | 20,200 | 195,994 | 176 K to 196 K (+11.36 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 42.38 | 7,157 | 303,314 | 946,524 | 953.7 K to 946.5 K (-0.75 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 43.25 | 700 | 30,275 | 953,681 | 954.4 K to 953.7 K (-0.07 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 43.07 | 12,396 | 533,896 | 954,381 | 966.8 K to 954.4 K (-1.28 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 43.80 | 7,547 | 330,559 | 966,777 | 974.3 K to 966.8 K (-0.77 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 45.01 | 2,200 | 99,022 | 974,324 | 976.5 K to 974.3 K (-0.23 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.19 | 1,916 | 86,584 | 5,325,391 | 5.3 M to 5.3 M (-0.04 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.09 | 17,664 | 796,470 | 5,327,307 | 5.3 M to 5.3 M (-0.33 %) |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | M | 14.08 | 14,900 | 209,792 | 140,000 | |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | M | 14.08 | 100 | 1,408 | 154,900 | |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 44.00 | 600 | 26,400 | 0 | 600 to 0 (-100.00 %) |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 44.55 | 14,300 | 637,065 | 600 | 14.9 K to 600 (-95.97 %) |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Buy | M | 14.08 | 14,900 | 209,792 | 14,900 | 0 to 14.9 K |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 44.19 | 100 | 4,419 | 0 | 100 to 0 (-100.00 %) |
Jan 15 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Buy | M | 14.08 | 100 | 1,408 | 100 | 0 to 100 |
Dec 28 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.75 | 50,704 | 88,732 | 32,758 | |
Dec 28 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.75 | 50,704 | 88,732 | 175,994 | 125.3 K to 176 K (+40.47 %) |
Dec 28 2020 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Sell | S | 40.04 | 220,000 | 8,808,800 | 1,804,118 | 2 M to 1.8 M (-10.87 %) |
Dec 22 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 41.95 | 265 | 11,117 | 19,285 | 19.6 K to 19.3 K (-1.36 %) |
Dec 22 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 41.95 | 1,042 | 43,712 | 951,558 | 952.6 K to 951.6 K (-0.11 %) |
Dec 22 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 41.95 | 3,012 | 126,353 | 2,263,627 | 2.3 M to 2.3 M (-0.13 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.00 | 697 | 29,274 | 19,550 | 20.2 K to 19.6 K (-3.44 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.00 | 2,785 | 116,970 | 952,600 | 955.4 K to 952.6 K (-0.29 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.00 | 8,053 | 338,226 | 2,266,639 | 2.3 M to 2.3 M (-0.35 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.13 | 766 | 32,272 | 20,247 | 21 K to 20.2 K (-3.65 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.13 | 3,060 | 128,918 | 955,385 | 958.4 K to 955.4 K (-0.32 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.13 | 8,849 | 372,808 | 2,274,692 | 2.3 M to 2.3 M (-0.39 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.08 | 6 | 264 | 21,013 | 21 K to 21 K (-0.03 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.12 | 30 | 1,294 | 21,019 | 21 K to 21 K (-0.14 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.40 | 2,432 | 103,117 | 21,049 | 23.5 K to 21 K (-10.36 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.08 | 24 | 1,058 | 958,445 | 958.5 K to 958.4 K (0.00 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.12 | 120 | 5,174 | 958,469 | 958.6 K to 958.5 K (-0.01 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.40 | 9,710 | 411,704 | 958,589 | 968.3 K to 958.6 K (-1.00 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.08 | 70 | 3,086 | 2,283,541 | 2.3 M to 2.3 M (0.00 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.12 | 349 | 15,049 | 2,283,611 | 2.3 M to 2.3 M (-0.02 %) |
Dec 17 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.40 | 28,078 | 1,190,507 | 2,283,960 | 2.3 M to 2.3 M (-1.21 %) |
Dec 16 2020 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | M | 14.08 | 25,000 | 352,000 | 155,000 | |
Dec 16 2020 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 42.09 | 389 | 16,373 | 0 | 389 to 0 (-100.00 %) |
Dec 16 2020 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 42.86 | 6,755 | 289,519 | 389 | 7.1 K to 389 (-94.55 %) |
Dec 16 2020 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Sell | S | 43.70 | 17,856 | 780,307 | 7,144 | 25 K to 7.1 K (-71.42 %) |
Dec 16 2020 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Buy | M | 14.08 | 25,000 | 352,000 | 25,000 | 0 to 25 K |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 3.30 | 12,590 | 41,547 | 121,691 | |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 3.30 | 12,590 | 41,547 | 125,290 | 112.7 K to 125.3 K (+11.17 %) |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 3.30 | 12,590 | 41,547 | 121,691 | |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 3.30 | 12,590 | 41,547 | 125,290 | 112.7 K to 125.3 K (+11.17 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.06 | 181 | 7,975 | 23,481 | 23.7 K to 23.5 K (-0.76 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.54 | 1,855 | 80,767 | 23,662 | 25.5 K to 23.7 K (-7.27 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.69 | 240 | 10,246 | 25,517 | 25.8 K to 25.5 K (-0.93 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.06 | 722 | 31,811 | 968,299 | 969 K to 968.3 K (-0.07 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.54 | 7,409 | 322,588 | 969,021 | 976.4 K to 969 K (-0.76 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.69 | 961 | 41,025 | 976,430 | 977.4 K to 976.4 K (-0.10 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.06 | 2,087 | 91,953 | 2,312,038 | 2.3 M to 2.3 M (-0.09 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.54 | 21,428 | 932,975 | 2,314,125 | 2.3 M to 2.3 M (-0.92 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.69 | 2,776 | 118,507 | 2,335,553 | 2.3 M to 2.3 M (-0.12 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.92 | 205 | 9,004 | 25,757 | 26 K to 25.8 K (-0.79 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.32 | 1,707 | 73,947 | 25,962 | 27.7 K to 26 K (-6.17 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.92 | 821 | 36,058 | 977,391 | 978.2 K to 977.4 K (-0.08 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.32 | 6,817 | 295,312 | 978,212 | 985 K to 978.2 K (-0.69 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.92 | 2,374 | 104,266 | 2,338,329 | 2.3 M to 2.3 M (-0.10 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.32 | 19,712 | 853,924 | 2,340,703 | 2.4 M to 2.3 M (-0.84 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.35 | 230 | 10,201 | 27,669 | 27.9 K to 27.7 K (-0.82 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.48 | 750 | 32,610 | 27,899 | 28.6 K to 27.9 K (-2.62 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.68 | 1,099 | 46,905 | 28,649 | 29.7 K to 28.6 K (-3.69 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.35 | 917 | 40,669 | 985,029 | 985.9 K to 985 K (-0.09 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.48 | 2,996 | 130,266 | 985,946 | 988.9 K to 985.9 K (-0.30 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.68 | 4,389 | 187,323 | 988,942 | 993.3 K to 988.9 K (-0.44 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 44.35 | 2,653 | 117,661 | 2,360,415 | 2.4 M to 2.4 M (-0.11 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 43.48 | 8,666 | 376,798 | 2,363,068 | 2.4 M to 2.4 M (-0.37 %) |
Dec 14 2020 | REPL | Replimune Group, I ... | Rhodes Jason P | Director | Sell | S | 42.68 | 12,691 | 541,652 | 2,371,734 | 2.4 M to 2.4 M (-0.53 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 42.39 | 3,863 | 163,753 | 1,305,297 | 1.3 M to 1.3 M (-0.30 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 42.99 | 16,051 | 690,032 | 1,309,160 | 1.3 M to 1.3 M (-1.21 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.72 | 5,086 | 222,360 | 1,325,211 | 1.3 M to 1.3 M (-0.38 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 42.03 | 800 | 33,624 | 1,330,297 | 1.3 M to 1.3 M (-0.06 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.09 | 11,116 | 478,988 | 1,331,097 | 1.3 M to 1.3 M (-0.83 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 43.88 | 6,459 | 283,421 | 1,342,213 | 1.3 M to 1.3 M (-0.48 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 44.85 | 6,025 | 270,221 | 1,348,672 | 1.4 M to 1.3 M (-0.44 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Sell | S | 45.79 | 600 | 27,474 | 1,354,697 | 1.4 M to 1.4 M (-0.04 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 41.97 | 1,000 | 41,970 | 976,524 | 977.5 K to 976.5 K (-0.10 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 43.10 | 13,750 | 592,625 | 977,524 | 991.3 K to 977.5 K (-1.39 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 43.90 | 7,058 | 309,846 | 991,274 | 998.3 K to 991.3 K (-0.71 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 44.83 | 7,492 | 335,866 | 998,332 | 1 M to 998.3 K (-0.74 %) |
Dec 11 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 45.82 | 700 | 32,074 | 1,005,824 | 1 M to 1 M (-0.07 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | SLATTERY JOSEPH P | Director | Option Exercise | M | 3.30 | 5,200 | 17,160 | 24,640 | |
Dec 09 2020 | REPL | Replimune Group, I ... | SLATTERY JOSEPH P | Director | Sell | S | 46.00 | 5,200 | 239,200 | 6,667 | 11.9 K to 6.7 K (-43.82 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | SLATTERY JOSEPH P | Director | Buy | M | 3.30 | 5,200 | 17,160 | 11,867 | 6.7 K to 11.9 K (+78.00 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Option Exercise | M | 1.75 | 40,000 | 70,000 | 3,169 | |
Dec 09 2020 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Sell | S | 47.04 | 1,802 | 84,766 | 0 | 1.8 K to 0 (-100.00 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Sell | S | 46.22 | 13,523 | 625,033 | 1,802 | 15.3 K to 1.8 K (-88.24 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Sell | S | 45.09 | 24,675 | 1,112,596 | 15,325 | 40 K to 15.3 K (-61.69 %) |
Dec 09 2020 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Buy | M | 1.75 | 40,000 | 70,000 | 40,000 | 0 to 40 K |
Nov 18 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 44.41 | 3,759 | 166,937 | 1,006,524 | 1 M to 1 M (-0.37 %) |
Nov 18 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 45.04 | 10,941 | 492,783 | 1,010,283 | 1 M to 1 M (-1.07 %) |
Nov 18 2020 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 46.43 | 300 | 13,929 | 1,021,224 | 1 M to 1 M (-0.03 %) |
Nov 03 2020 | REPL | Replimune Group, I ... | Lewis Tanya | Director | Option Exercise | A | 42.00 | 33,000 | 1,386,000 | 33,000 | |
Oct 16 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 16,000 | 16,160 | 128,203 |